Search all trials

Find therapies in clinical trials near you – page 23

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Bladder cancer+2

Not recruiting

Registered drug

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Mk-0482

Contact Research Centre

Hormone receptor positive breast cancer+1

Not recruiting

Registered drugNo placebo

Study on Time Savings with Subcutaneous Pertuzumab and Trastuzumab for Patients with HER2-Positive Early Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pertuzumab

Contact Research Centre

Follicular lymphoma+1

Not recruiting

Registered drug

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Lenalidomide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Boserolimab

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Not recruiting

Investigational

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Azd4831

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carfilzomib

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Registered drug

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Autoimmune haemolytic anaemia+1

Not recruiting

Registered drugNo placebo

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drug

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Neoplasm

Not recruiting

InvestigationalNo placebo

Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Find therapies in clinical trials near you – page 23

296 trials match your criteria

Bladder cancer+2

Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

Non-small cell lung cancer

Study to Test Pembrolizumab, MK-4830, and MK-0482 in Patients with Advanced Non-Small Cell Lung Cancer Who Have Not Received Prior Treatment

Hormone receptor positive breast cancer+1

Study on Time Savings with Subcutaneous Pertuzumab and Trastuzumab for Patients with HER2-Positive Early Breast Cancer

Follicular lymphoma+1

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Non-small cell lung cancer

Study of Boserolimab, MK-0482, and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-(L)1 Therapy

Breast cancer+2

Study on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy

Metabolic dysfunction-associated steatohepatitis+1

Study on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis

Plasma cell myeloma

Long-term Safety Study of Daratumumab with Drug Combination for Patients with Multiple Myeloma or Smoldering Multiple Myeloma

Hormone-refractory prostate cancer+1

Study of Pembrolizumab and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

Autoimmune haemolytic anaemia+1

Study for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab

Triple negative breast cancer

Study of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer

Neoplasm

Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.